The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like Biocept Announces Private Placement Of $2.2 Million Of Common Stock With August 9, 2017 Targovax: Invitation To First Quarter 2017 Results Presentation Tuesday 25 April April 18, 2017 Phosphagenics Limited Signs Development Agreement For TPM/Oxymorphone Patch In Japan August 21, 2017
